The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(Dimethylamino)-N-(3-{2-[(2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)oxy]acetamido}phenyl)benzamide ID: ALA4476081
PubChem CID: 155537760
Max Phase: Preclinical
Molecular Formula: C26H26N4O4
Molecular Weight: 458.52
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(c3)CCC(=O)N4)c2)cc1
Standard InChI: InChI=1S/C26H26N4O4/c1-30(2)21-9-6-17(7-10-21)26(33)28-20-5-3-4-19(15-20)27-25(32)16-34-22-11-12-23-18(14-22)8-13-24(31)29-23/h3-7,9-12,14-15H,8,13,16H2,1-2H3,(H,27,32)(H,28,33)(H,29,31)
Standard InChI Key: ZIOSPUHRWHMHJG-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 37 0 0 0 0 0 0 0 0999 V2000
3.7284 -13.7454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7284 -14.5649 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0203 -14.9726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4365 -14.9726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1425 -14.5658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8534 -14.9714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8534 -15.7918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1451 -16.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4365 -15.7924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5615 -16.2035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5615 -17.0230 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2696 -15.7918 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9817 -16.2035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9817 -17.0236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6881 -17.4290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3939 -17.0224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3939 -16.2030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1061 -15.7913 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8142 -16.2030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8142 -17.0224 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5223 -15.7913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2303 -16.2030 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.9425 -15.7913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9425 -14.9717 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6484 -14.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3590 -14.9745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3590 -15.7882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6508 -16.2055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0673 -16.1952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7670 -15.7885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7670 -14.9708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0628 -14.5679 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.4792 -14.5630 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6897 -15.7923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 0
4 2 1 0
5 4 1 0
6 5 2 0
7 6 1 0
8 7 2 0
9 8 1 0
4 9 2 0
10 7 1 0
10 11 2 0
12 10 1 0
13 12 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 20 2 0
19 21 1 0
21 22 1 0
22 23 1 0
24 23 2 0
25 24 1 0
26 25 2 0
27 26 1 0
28 27 2 0
23 28 1 0
27 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
26 32 1 0
31 33 2 0
17 34 1 0
34 13 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 458.52Molecular Weight (Monoisotopic): 458.1954AlogP: 3.91#Rotatable Bonds: 7Polar Surface Area: 99.77Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.47CX Basic pKa: 3.16CX LogP: 3.47CX LogD: 3.47Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.50Np Likeness Score: -1.53
References 1. Zhao L, Li Y, Wang Y, Qiao Z, Miao Z, Yang J, Huang L, Tian C, Li L, Chen D, Yang S.. (2019) Discovery of 4H-Chromen-4-one Derivatives as a New Class of Selective Rho Kinase (ROCK) Inhibitors, which Showed Potent Activity in ex Vivo Diabetic Retinopathy Models., 62 (23): [PMID:31693351 ] [10.1021/acs.jmedchem.9b01143 ]